Menu
Amgen is one of four drugmakers to have recently exempted new states from its 340B contract pharmacy restrictions.

Four Drugmakers Announce New State Exemptions from 340B Contract Pharmacy Restrictions

William Newton, Associate Editor/Senior Writer 340B Report Views
Drugmakers Amgen, GSK, Merck and Sobi recently announced they are exempting more states from their 340B contract pharmacy restrictions amid [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Lauren Navas, Chief Marketing Officer, Ravin Consultants

RFK Jr. Touts HHS Budget Plan, PBM Reform & Drug Pricing Efforts; Rep. Harshbarger Suggests 340B Contract Changes

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live